Table 1.
Clinical variables-wise categorization of the BRCA cohort analyzed via UALCAN
Sr. No | Clinical variable | Samples count per variable | Total samples count | Sample count having missing details | Final sample count subjected to analysis |
---|---|---|---|---|---|
1 | Cancer stage | ||||
Stage 1 | n, 183 | n, 32 | n, 1065 | ||
Stage 2 | n, 615 | ||||
Stage 3 | n, 247 | ||||
Stage 4 | n, 20 | ||||
2 | Age | ||||
years = 21-40 | n, 97 | n, 1097 | n, 10 | n, 1087 | |
years = 41-60 | n, 505 | ||||
years = 61-80 | n, 431 | ||||
years = 81-100 | n, 54 | ||||
3 | Geographical distribution | ||||
Caucasian | n, 748 | n, 109 | n, 988 | ||
African-American | n, 179 | ||||
Asian | n, 61 | ||||
4 | TP53 mutation status | ||||
TP53-Mutatnt | n, 334 | n, 65 | n, 1032 | ||
TP53-NonMutant | n, 698 |
BRCA = Breast Cancer, UALCAN = University of ALabama at Birmingham CANcer.